Zinc acetate/carrageenan gels exhibit potent activity in vivo against high-dose herpes simplex virus 2 vaginal and rectal challenge.
about
Multipurpose prevention technologies: the future of HIV and STI protectionGreentree white paper: sexual violence, genitoanal injury, and HIV: priorities for research, policy, and practice.In vitro and in vivo evaluation of two carrageenan-based formulations to prevent HPV acquisition.Zinc therapy in dermatology: a reviewProphylactic treatment with a novel bioadhesive gel formulation containing aciclovir and tenofovir protects from HSV-2 infection.A potent combination microbicide that targets SHIV-RT, HSV-2 and HPVAn intravaginal ring that releases the NNRTI MIV-150 reduces SHIV transmission in macaquesAlternative divalent cations (Zn²⁺, Co²⁺, and Mn²⁺) are not mutagenic at conditions optimal for HIV-1 reverse transcriptase activity.Seminal plasma accelerates semen-derived enhancer of viral infection (SEVI) fibril formation by the prostatic acid phosphatase (PAP248-286) peptide.Chitosan and Kappa-Carrageenan Vaginal Acyclovir Formulations for Prevention of Genital Herpes. In Vitro and Ex Vivo Evaluation.Griffithsin and Carrageenan Combination To Target Herpes Simplex Virus 2 and Human Papillomavirus.A single dose of a MIV-150/Zinc acetate gel provides 24 h of protection against vaginal simian human immunodeficiency virus reverse transcriptase infection, with more limited protection rectally 8-24 h after gel use.The nonnucleoside reverse transcription inhibitor MIV-160 delivered from an intravaginal ring, but not from a carrageenan gel, protects against simian/human immunodeficiency virus-RT Infection.A novel intravaginal ring to prevent HIV-1, HSV-2, HPV, and unintended pregnancyPolymer nanoparticles encapsulating siRNA for treatment of HSV-2 genital infection.Multipurpose Prevention Approaches with Antiretroviral-Based FormulationsIn search of the optimal delivery method for anti-HIV microbicides: are intravaginal rings the way forward?Filoviruses utilize glycosaminoglycans for their attachment to target cells.Monitoring vaginal epithelial thickness changes noninvasively in sheep using optical coherence tomography.A modified zinc acetate gel, a potential nonantiretroviral microbicide, is safe and effective against simian-human immunodeficiency virus and herpes simplex virus 2 infection in vivo.Clinical use of vaginal or rectally applied microbicides in patients suffering from HIV/AIDS.First-in-Human Trial of MIV-150 and Zinc Acetate Coformulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence, and Pharmacodynamics.A combination microbicide gel protects macaques against vaginal simian human immunodeficiency virus-reverse transcriptase infection, but only partially reduces herpes simplex virus-2 infection after a single high-dose cochallenge.An update on multipurpose prevention technologies for the prevention of HIV transmission and pregnancy.MZC Gel Inhibits SHIV-RT and HSV-2 in Macaque Vaginal Mucosa and SHIV-RT in Rectal Mucosa.MIV-150 and zinc acetate combination provides potent and broad activity against HIV-1.An intravaginal ring that releases three antiviral agents and a contraceptive blocks SHIV-RT infection, reduces HSV-2 shedding, and suppresses hormonal cycling in rhesus macaques.Formulation and Evaluation of Antibacterial Creams and Gels Containing Metal Ions for Topical Application.Effects of iota-carrageenan on ocular infection in vitro and in vivoGriffithsin carrageenan fast dissolving inserts prevent SHIV HSV-2 and HPV infections in vivo
P2860
Q26827796-954FA2D1-D244-4935-9261-B4D78A70C8D1Q30416473-60AF28A3-14FF-4E40-8517-D3585315B359Q33978803-A78B7C9D-6279-42B7-9071-F50F4DE3D8C5Q33998002-01006007-979F-48A8-A6E8-412E71FF9D6AQ34495644-FBD7A5C7-EB01-4581-A4DB-AFA0129B1660Q35150470-55624A04-5E7A-444A-B02C-0AB1E6328F59Q35345363-42A759E2-F642-48AF-BAB0-2FF99ED526AEQ35620768-2224AFE8-437C-43CE-9EFF-A0E5A3D3968CQ35874384-3F75EFF7-C95C-4EA4-BD96-344ED80D1444Q36096590-97A43E88-BEBF-400B-81AE-D82AAF297A2EQ36290533-A730888B-6067-4430-AEB2-132F30E63C1FQ36359120-7231CA45-FC4D-4943-AAF0-523E0B7B3837Q36359133-7E6D2389-64FD-44CA-B6A8-A6A3411BED13Q36381485-A479156C-1D49-4036-B6CF-9DA1C1FB83E4Q36528415-A50754CB-96AA-4B73-AA3F-4A163754113AQ36571872-CA121DF9-6CDD-40F5-8C39-A5467E4F8BFEQ36630547-9B481355-B865-4B72-B8C2-F58D72D744B8Q36667804-CE3F65A5-FCD3-43C7-B128-F1E5B5452412Q36724657-1998D3F7-60D8-4ED9-8A51-720BAE25B8F1Q37036620-5D2B2E34-18AC-48AE-9A59-017332E292A1Q37255082-B259219A-1711-40BF-B229-6971D608477AQ37520083-EF8E6D03-B05D-45B6-B3B2-D5C564052C16Q37544128-C7B8A0A6-B807-4BEE-94DA-1113635299DAQ38689686-1EF9CA28-118A-4BF6-BA32-7251C68BA0E8Q39463175-FE6B4C07-C06D-42AB-A31C-6D2FDF771BC4Q40081674-6A3E239A-054F-4CB3-84D6-5D5D10ABA3E3Q40165275-83947AFD-B93D-45FC-B641-A2A207FA5561Q40436556-BBB01D27-6FD3-484E-B955-82A73A68EF3BQ57096139-B14DC31B-F715-4275-BED5-FD160A1B1A4AQ58700581-D5443A53-79B7-4BE7-961D-2AA01C482144
P2860
Zinc acetate/carrageenan gels exhibit potent activity in vivo against high-dose herpes simplex virus 2 vaginal and rectal challenge.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Zinc acetate/carrageenan gels ...... vaginal and rectal challenge.
@ast
Zinc acetate/carrageenan gels ...... vaginal and rectal challenge.
@en
type
label
Zinc acetate/carrageenan gels ...... vaginal and rectal challenge.
@ast
Zinc acetate/carrageenan gels ...... vaginal and rectal challenge.
@en
prefLabel
Zinc acetate/carrageenan gels ...... vaginal and rectal challenge.
@ast
Zinc acetate/carrageenan gels ...... vaginal and rectal challenge.
@en
P2093
P2860
P356
P1476
Zinc acetate/carrageenan gels ...... 2 vaginal and rectal challenge
@en
P2093
Aixa Rodriguez
Ciby J Abraham
David Katz
Jennifer Peters
José A Fernández-Romero
Larisa Kizima
Melissa Robbiani
Ninochka Jean-Pierre
Othell Begay
Pedro I Gil
P2860
P304
P356
10.1128/AAC.05461-11
P407
P50
P577
2011-11-07T00:00:00Z